Hertford, United Kingdom · Founded 2017 · Privately Held (backing)
Operator of a vaccine antigen design company intended to accelerate vaccine development to maximize the protection against existing and future viruses. DIOSynVax is based in Hertford, United Kingdom and was founded in 2017. Its last reported valuation was $31.6 million in Dec 2025. It has raised $9.8 million.
Last reported valuation
$31.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
—
Team — not yet on record
No current team members for DIOSynVax are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of DIOSynVax with a free Private Market View account
·Watch DIOSynVax: the Monday email on marks, rounds and moves
